LifeStance Health Group, Inc. vs GeneDx Holdings Corp., two Medical Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
The margin lines separate a business finding its footing from one still buying it: LifeStance earns a positive 5.5% operating margin on outpatient mental-health visits, GeneDx a negative 56.2% on genomic diagnostics, spending through a 66.7% gross margin toward scale. LifeStance converts 3.5% of its price into free cash; GeneDx burns modestly against a 3.1 current ratio. Neither has earnings to price. The market values them within a factor of two, $4B against $2B, which prices GeneDx's sequencing growth story at a substantial premium per current dollar of anything. Behavioral health compounding quietly against genomics compounding loudly; the quiet one is closer to paying for itself.
Comparison updated 2026-07-10.
| Metric | LFST | WGS |
|---|---|---|
| Price | $10.26 | $69.86 |
| Market cap | $4.1B | $2.0B |
| Sector | Medical Services | Medical Services |
| Stage | Growth | Growth |
| P/B | 2.74 | 8.06 |
| P/S | 2.71 | 4.63 |
| EV/EBITDA | 42.0 | — |
| Revenue growth | +16.4% | +35.3% |
| Gross margin | — | 66.7% |
| Operating margin | 5.5% | -56.2% |
| Net margin | 1.6% | -17.6% |
| Return on equity | 1.6% | -30.6% |
| Return on assets | 1.1% | -15.4% |
| Return on invested capital | 1.8% | -14.7% |
| FCF yield | 3.5% | -1.4% |
| Debt / equity | 0.20 | 0.39 |
| Current ratio | 1.48 | 3.09 |
| Altman Z (solvency) | 3.92 | 1.84 |
| Piotroski F (quality) | 6 / 9 | 1 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.